Literature DB >> 16212138

Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study.

Robert N Foley1, Changchun Wang, Allan J Collins.   

Abstract

OBJECTIVE: To determine the prevalence of cardiovascular risk factors in the general population based on kidney function. SUBJECTS AND METHODS: We retrospectively analyzed data from the Third National Health and Nutrition Examination Survey of noninstitutionalized US adults, which was conducted from 1988 to 1994. Data were gathered on 9 cardiovascular risk factors (smoking; obesity; hypertension; high total cholesterol, C-reactive protein, glycosylated hemoglobin, and homocysteine levels; low hemoglobin level; and high urinary albumin-to-creatinine ratio) and estimated glomerular filtration rate (GFR).
RESULTS: For the 15,837 subjects, the estimated GFR was at least 90 mL/min per 1.73 m2 (normal) in 65.4%, 60 to 89.9 mL/ min per 1.73 m2 (stage 2 kidney function) in 27.9%, 30 to 59.9 mL/min per 1.73 m2 (stage 3 kidney function) in 6.2%, and less than 30 mL/min per 1.73 m2 (stages 4 and 5 kidney function) In 0.5%. The number of cardiovascular risk factors Increased with stage of kidney dysfunction. Of subjects with a normal GFR, 30.4% had no risk factors, 34.9% had 1 risk factor, and 34.7% had 2 or more risk factors. Of subjects with stage 2 kidney function, 24.8% had no risk factors, 30.3% had 1 risk factor, and 44.9% had 2 or more risk factors. Of subjects with stage 3 kidney function, 1.4% had no risk factors, 14.9% had 1 risk factor, and 83.6% had 2 or more risk factors. All subjects with stages 4 and 5 kidney function had 2 or more risk factors. After covariate adjustment, odds ratios for having an estimated GFR lower than 60 mL/min per 1.73 m2 were 1, 3.7 (95% confidence interval, 1.2-11.3), and 10.4 (95% confidence interval, 3.9-27.8) times greater in subjects with 0, 1, and 2 or more cardiovascular risk factors, respectively (P<.001).
CONCLUSION: Persons with chronic kidney disease are much more likely to need multiple cardiovascular risk factor interventions than those without chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212138     DOI: 10.4065/80.10.1270

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  31 in total

1.  Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome.

Authors:  Federico Guerra; Lucia Mancinelli; Alessia Buglioni; Valentina Pierini; Alessandro Rappelli; Paolo Dessì-Fulgheri; Riccardo Sarzani
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-12-01

Review 2.  Use of metformin in diseases of aging.

Authors:  John M Miles; Andrew D Rule; Barry A Borlaug
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

3.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

Review 4.  Chronic kidney disease as a coronary artery disease risk equivalent.

Authors:  Alexandrios Briasoulis; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

5.  p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.

Authors:  Björn K I Meijers; Kathleen Claes; Bert Bammens; Henriette de Loor; Liesbeth Viaene; Kristin Verbeke; Dirk Kuypers; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 8.237

Review 6.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

7.  Chronic kidney disease and mortality in implantable cardioverter-defibrillator recipients.

Authors:  Aamir Cheema; Tejwant Singh; Manreet Kanwar; Karuna Chilukuri; Viqar Maria; Fareena Saleem; Katrina Johnson; John Frank; Luis Pires; Sohail Hassan
Journal:  Cardiol Res Pract       Date:  2010-08-03       Impact factor: 1.866

8.  Response to the review by Fisher and Ma.

Authors:  Effie Ioannidou; Helen Swede; Anna Dongari-Bagtzoglou
Journal:  J Evid Based Dent Pract       Date:  2013-03       Impact factor: 5.267

Review 9.  Cardiovascular risk and management in chronic kidney disease.

Authors:  Diana Rucker; Marcello Tonelli
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

10.  Role of open nephron sparing surgery in the era of minimal invasive surgery.

Authors:  Gaurav Gupta; Sameer Grover; Santosh Kumar; Nitin S Kekre
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.